Related Experiment Video
Updated: May 15, 2025

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death
Published on: October 31, 2017
Broad PFAS binding with fatty acid binding protein 4 is enabled by variable binding modes.
Aaron S Birchfield1, Faik N Musayev2,3, Abdul J Castillo1
1Department of Chemistry, Virginia Commonwealth University, Richmond, VA 23284, U.S.A.
Human adipocyte fatty acid-binding protein (FABP4) binds various per- and polyfluoroalkyl substances (PFAS), including replacements for legacy chemicals. Structural analysis reveals distinct binding modes, impacting toxicological outcomes and metabolic regulation.
Area of Science:
- Environmental Chemistry
- Structural Biology
- Toxicology
Background:
- Per- and polyfluoroalkyl substances (PFAS) are widespread environmental pollutants known to bioaccumulate.
- The molecular mechanisms underlying PFAS interactions with biological proteins are not well understood.
- Human adipocyte fatty acid-binding protein (FABP4) plays a role in metabolic regulation and endocrine function.
Purpose of the Study:
- To investigate the binding interactions between FABP4 and a diverse range of PFAS.
- To elucidate the structural basis of PFAS-FABP4 complex formation.
- To understand how PFAS binding to FABP4 may influence metabolic processes and disease risk.
Main Methods:
- Fluorescence competition assays to measure binding affinities.
- X-ray crystallography to determine the structures of FABP4 in complex with specific PFAS (PFOA, PFDA, PFHxDA).
- Analysis of binding modes and their correlation with chemical properties.
Main Results:
- FABP4 binds a variety of PFAS, including newer replacements and longer-chain compounds.
- Shorter-chain PFAS exhibit measurable binding affinities to FABP4, exceeding those of nonfluorinated analogs.
- Crystal structures reveal three distinct binding modes for PFOA, PFDA, and PFHxDA, with PFOA binding in two sites.
- Binding modes involve enhanced hydrophobic interactions and distinct protein conformations, explaining observed affinities.
Conclusions:
- PFAS-FABP4 interactions are influenced by PFAS chain length, headgroup, and protein conformation.
- PFAS binding to FABP4, even at low affinities, could perturb metabolic regulation due to FABP4's role in endocrine function.
- Structural and biochemical insights are crucial for understanding PFAS transport and toxicological effects.
More Related Videos
08:49Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
Published on: March 14, 2021
06:38High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
Published on: February 7, 2019
Related Concept Videos
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Ligand Binding and Linkage
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Drug Distribution: Plasma Protein Binding